Delivery Order SPE2DE24D0013-SPE2D625F7VL2
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with...
- The U.S. Defense department's Medical Supply Chain agency awarded a delivery order valued at $1,440 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on July 28, 2025. This firm fixed-price delivery order, designated as 4568910320 and issued under the GXCDIFF/EPI-10 vehicle, carries an ultimate completion date of August 4, 2025, with no set-aside designation. The award represents a continuation of the federal government's procurement of Cepheid's advanced...
- The Defense or Civilian agency within Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 22, 2025, with an ultimate completion date of July 29, 2025. This contract, identified as XPRSARS-COV2-10, involves delivery of molecular diagnostic solutions to the Sunnyvale, California location. The award carries no set-aside designation and represents a delivery order against one of Cepheid's existing Indefinite Delivery Vehicle contracts...
- This delivery order, awarded July 30, 2025, by the Defense Logistics Agency (under the Medical Supply Chain operations) to Cepheid Inc., carries a firm fixed-price ceiling value of $27,235.80 with an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and is performed in Sunnyvale, California, where Cepheid maintains its headquarters. Cepheid, a for-profit manufacturer of molecular diagnostic solutions, will deliver products or services under this...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $9,779.30 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents a discrete procurement of molecular diagnostic solutions for defense-related medical supply needs. The work will be performed at Cepheid's facility in Sunnyvale, California....
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,104 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award builds upon Cepheid's extensive track record providing molecular diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F7VL2Delivery Order
The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $1,277.84 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 21, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order represents a continuation of Cepheid's established relationship with federal defense and healthcare agencies as a leading provider of molecular diagnostic solutions. Cepheid specializes in advanced diagnostic systems and molecular test kits for infectious diseases, genetic conditions, and clinical testing. The company maintains significant federal Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the Veterans Affairs system, including a $32.8 million single-award IDIQ with VA's Veterans Integrated Service Network 6 through September 30, 2030, which supplies molecular diagnostic testing system reagents and assays. This particular delivery order aligns with Cepheid's core federal contracting portfolio, which focuses on providing GeneXpert diagnostic systems, reagents, and testing services for detecting conditions including COVID-19, influenza, respiratory syncytial virus, and other infectious diseases across multiple federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/21/25 |